# Task B06: PROCESS DEVELOPMENT AND SYNTHESIS OF A THERAPEUTIC FOR LASSA FEVER VIRUS

> **NIH NIH N01** · SRI INTERNATIONAL · 2020 · $7,489

## Abstract

The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.

## Key facts

- **NIH application ID:** 10092040
- **Project number:** 272201800001I-P00002-759301900135-1
- **Recipient organization:** SRI INTERNATIONAL
- **Principal Investigator:** JON MIRSALIS
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $7,489
- **Award type:** —
- **Project period:** 2019-07-25 → 2020-07-01

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10092040

## Citation

> US National Institutes of Health, RePORTER application 10092040, Task B06: PROCESS DEVELOPMENT AND SYNTHESIS OF A THERAPEUTIC FOR LASSA FEVER VIRUS (272201800001I-P00002-759301900135-1). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10092040. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*